Achaogen Company Profile (NASDAQ:AKAO)

About Achaogen

Achaogen logoAchaogen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterials to treat multi-drug resistant (MDR) gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant enterobacteriaceae (CRE). Plazomicin is an aminoglycoside designed to overcome clinically relevant aminoglycoside resistance mechanisms. In addition, its research and development pipeline includes two programs that specifically target Pseudomonas aeruginosa or Acinetobacter baumannii infections: a program to discover and develop small molecule inhibitors of LpxC, which is an enzyme essential for the synthesis of the outer membrane of gram-negative bacteria, and a therapeutic antibody program. Its development plan for plazomicin includes over two Phase III clinical trials.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AKAO
  • CUSIP:
Key Metrics:
  • Previous Close: $3.78
  • 50 Day Moving Average: $3.80
  • 200 Day Moving Average: $3.58
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.80
  • P/E Growth: 0.00
  • Market Cap: $99.78M
  • Outstanding Shares: 26,679,000
  • Beta: 0.59
Additional Links:
Companies Related to Achaogen:

Analyst Ratings

Consensus Ratings for Achaogen (NASDAQ:AKAO) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $10.00 (168.82% upside)

Analysts' Ratings History for Achaogen (NASDAQ:AKAO)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2016Needham & Company LLCReiterated RatingHoldView Rating Details
6/14/2016WedbushUpgradeNeutral -> Outperform$7.00 -> $10.00View Rating Details
3/31/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
8/10/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details
3/2/2015Credit Suisse Group AGDowngradeOutperform -> Underperform$22.00 -> $13.00View Rating Details
11/3/2014SunTrust Banks Inc.Initiated CoverageBuy$22.00View Rating Details
10/30/2014Canaccord GenuityInitiated CoverageBuy$13.00View Rating Details
9/19/2014GabelliUpgradeHold -> Buy$19.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Achaogen (NASDAQ:AKAO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/8/2016Q2($0.67)($0.87)$5.58 million$9.14 millionViewN/AView Earnings Details
3/15/2016Q414($0.58)($0.61)$5.33 million$4.70 millionViewListenView Earnings Details
11/5/2015($0.45)($0.48)ViewN/AView Earnings Details
8/10/2015($0.20)($0.05)ViewN/AView Earnings Details
5/11/2015($0.26)($0.34)ViewN/AView Earnings Details
3/16/2015($0.33)($0.27)ViewN/AView Earnings Details
11/10/2014Q314($0.25)($0.47)$6.00 million$4.52 millionViewN/AView Earnings Details
8/11/2014($0.19)($0.20)ViewN/AView Earnings Details
5/12/2014Q114($0.48)($1.00)$5.39 million$6.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Achaogen (NASDAQ:AKAO)
Current Year EPS Consensus Estimate: $-2.71 EPS
Next Year EPS Consensus Estimate: $-2.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.71)($0.52)($0.62)
Q2 20164($0.71)($0.52)($0.62)
Q3 20163($0.53)($0.33)($0.43)
Q4 20163($0.63)($0.41)($0.48)
Q1 20171($0.56)($0.56)($0.56)
Q2 20171($0.67)($0.67)($0.67)
Q3 20171($0.72)($0.72)($0.72)
Q4 20171($0.67)($0.67)($0.67)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Achaogen (NASDAQ:AKAO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Achaogen (NASDAQ:AKAO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/17/2016Ian FriedlandInsiderSell1,772$3.22$5,705.84View SEC Filing  
3/17/2016Kenneth J HillanCEOSell3,572$3.22$11,501.84View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Achaogen (NASDAQ:AKAO)
DateHeadline
publicnow.com logoAchaogen Announces New Employment Inducement Grants (NASDAQ:AKAO)
www.publicnow.com - August 22 at 8:12 AM
investornewswire.com logoWill Achaogen, Inc. (NASDAQ:AKAO) Hit $11 Price Target? - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - August 21 at 8:11 AM
biz.yahoo.com logoACHAOGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:AKAO)
biz.yahoo.com - August 18 at 8:53 PM
finance.yahoo.com logoACHAOGEN INC Financials (NASDAQ:AKAO)
finance.yahoo.com - August 16 at 3:25 PM
globenewswire.com logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference - GlobeNewswire (press release) (NASDAQ:AKAO)
globenewswire.com - August 10 at 3:45 PM
finance.yahoo.com logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference (NASDAQ:AKAO)
finance.yahoo.com - August 10 at 11:14 AM
globenewswire.com logoAchaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO)
globenewswire.com - August 8 at 8:52 PM
twst.com logoAchaogen Inc.: Achaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO)
www.twst.com - August 8 at 8:52 PM
sg.finance.yahoo.com logoAchaogen reports 2Q loss (NASDAQ:AKAO)
sg.finance.yahoo.com - August 8 at 8:52 PM
equities.com logoAchaogen Inc. (AKAO) Drops 7.12% on August 01 - Equities.com (NASDAQ:AKAO)
www.equities.com - August 3 at 11:58 AM
ftsenews.co.uk logoAchaogen, Inc. (AKAO) Updated Price Targets - FTSE News (NASDAQ:AKAO)
www.ftsenews.co.uk - August 1 at 8:12 AM
investornewswire.com logoIs $12 Price Target Attainable For Achaogen, Inc. (NASDAQ:AKAO)? - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 24 at 8:10 AM
News IconStock Up Nicely This Week: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 23 at 3:24 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 22 at 11:36 AM
fiscalstandard.com logoBroker Outlook For Achaogen, Inc. (AKAO) - Fiscal Standard (NASDAQ:AKAO)
www.fiscalstandard.com - July 21 at 8:58 PM
News IconAchaogen Inc Increases Again; Strong Momentum for Buyers - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 21 at 3:24 PM
News IconAchaogen Inc's Trend Up, Especially After Today's Strong Session - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 21 at 3:24 PM
News IconIs Achaogen Inc's Fuel Running Low? The Stock Just Declined Again - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 20 at 10:51 PM
News IconIncreased Stock Volatility Watch: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 20 at 10:51 PM
News IconShares Jumping Higher in Session: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 20 at 10:51 PM
equities.com logoAchaogen Inc. (AKAO) Jumps 9.63% on July 20 - Equities.com (NASDAQ:AKAO)
www.equities.com - July 20 at 10:51 PM
4-traders.com logoAchaogen Inc : LifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO)
www.4-traders.com - July 20 at 4:29 PM
News IconAchaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 30.9% Their Shorts - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 19 at 8:51 PM
finance.yahoo.com logoLifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO)
finance.yahoo.com - July 19 at 1:45 PM
News IconInvestor Watch: Volatility Recap on Shares of: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 18 at 3:27 PM
finance.yahoo.com logoCerulean Pharma (CERU) Worth a Look: Stock Gains 9.1% (NASDAQ:AKAO)
finance.yahoo.com - July 18 at 8:45 AM
investornewswire.com logoStrong Sell Calls For Achaogen, Inc. (NASDAQ:AKAO) At 0 - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 17 at 8:10 AM
News IconAchaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 44.43% Their Shorts - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 16 at 3:24 PM
ftsenews.co.uk logoNew Broker Ratings For Achaogen, Inc. (AKAO) - FTSE News (NASDAQ:AKAO)
www.ftsenews.co.uk - July 15 at 7:41 PM
News IconShares Experiencing a Downtrend: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 15 at 7:41 PM
News IconIncreased Volatility Noted on Shares of: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 15 at 2:00 PM
publicnow.com logoAchaogen to Host Key Opinion Leader Meeting on Multi-Drug Resistant Infections on July 19, 2016 in New York (NASDAQ:AKAO)
www.publicnow.com - July 15 at 8:28 AM
finance.yahoo.com logoFoamix Pharmaceuticals (FOMX) Jumps: Stock Rises 7.1% (NASDAQ:AKAO)
finance.yahoo.com - July 15 at 8:25 AM
News IconInstitutional Investor Sentiment About Achaogen Inc (NASDAQ:AKAO) Increased - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 12 at 3:28 PM
News IconTrading Performance and Target Watch for Achaogen, Inc. (NASDAQ:AKAO) - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 12 at 8:32 AM
News IconWill Achaogen Inc Short Squeeze Soon? The Stock Formed a Bearish Double Bottom Pattern - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 11 at 8:29 PM
News IconAchaogen, Inc. (NASDAQ:AKAO) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 11 at 3:25 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Achaogen, Inc. (AKAO) - Fiscal Standard (NASDAQ:AKAO)
www.fiscalstandard.com - July 10 at 3:23 PM
investornewswire.com logoIs $12 Within Reach For Achaogen, Inc. (NASDAQ:AKAO)? - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 10 at 8:09 AM
News IconWall Street Ratings and Target Price Views on Achaogen, Inc. (NASDAQ:AKAO) - Telanagana Press (NASDAQ:AKAO)
telanaganapress.com - July 8 at 11:28 AM
News IconAchaogen, Inc. (NASDAQ:AKAO) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:AKAO)
telanaganapress.com - July 7 at 3:26 PM
News IconStock Rating Watch and Earnings Insight for Achaogen, Inc. (NASDAQ:AKAO) - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 6 at 8:13 AM
fiscalstandard.com logoAchaogen, Inc. (AKAO) Current Analyst Ratings - Fiscal Standard (NASDAQ:AKAO)
www.fiscalstandard.com - July 6 at 8:13 AM
equities.com logoAchaogen Inc. (AKAO) Jumps 5.01% on July 04 - Equities.com (NASDAQ:AKAO)
www.equities.com - July 6 at 8:13 AM
News IconAchaogen Inc Stock Is Rising Now - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 5 at 8:12 AM
investornewswire.com logoAchaogen, Inc. (NASDAQ:AKAO) Expected to Reach Highs Of $12 - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 3 at 8:10 AM
equities.com logoAchaogen Inc. (AKAO) Jumps 5.01% on July 01 - Equities.com (NASDAQ:AKAO)
www.equities.com - July 1 at 8:39 PM
News IconShares Headed Up in Session: Achaogen, Inc. (NASDAQ:AKAO) - Telanagana Press (NASDAQ:AKAO)
telanaganapress.com - July 1 at 3:26 PM
News IconAchaogen, Inc. (NASDAQ:AKAO) Company Rating and Target Watch - Telanagana Press (NASDAQ:AKAO)
telanaganapress.com - June 30 at 3:27 PM
News IconAchaogen Incorporated (NASDAQ:AKAO) Short Interest Increased By 44.43% - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - June 29 at 8:34 PM

Social

Achaogen (NASDAQ:AKAO) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff